Pressure Biosciences Inc
(PBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 1,978 | 1,729 | 2,002 | 1,221 | 1,810 |
| Cost of Goods | 1,178 | 2,014 | 942 | 583 | 1,197 |
| Gross Profit | 800 | -285 | 1,060 | 638 | 613 |
| Operating Expenses | 10,481 | 4,628 | 6,188 | 5,806 | 6,616 |
| Operating Income | -9,503 | -4,898 | -4,185 | -4,586 | -5,806 |
| Interest Expense | 15,581 | 10,439 | 14,450 | 8,344 | 5,282 |
| Other Income | -4,230 | -740 | -1,518 | -3,076 | -791 |
| Pre-tax Income | -29,314 | -16,077 | -20,154 | -16,006 | -11,878 |
| Income Tax | N/A | N/A | N/A | N/A | -217 |
| Net Income Continuous | -29,314 | -16,077 | -20,154 | -16,006 | -11,661 |
| Net Income | $-29,314 | $-16,077 | $-20,154 | $-16,006 | $-11,661 |
| EPS Basic Total Ops | -1.51 | -1.61 | -3.42 | -5.32 | -7.98 |
| EPS Basic Continuous Ops | -1.26 | -1.45 | -3.04 | -4.84 | -5.87 |
| EPS Diluted Total Ops | -1.51 | -1.61 | -3.42 | -5.32 | -7.98 |
| EPS Diluted Continuous Ops | -1.26 | -1.45 | -3.04 | -4.84 | -5.87 |
| EPS Diluted Before Non-Recurring Items | -1.51 | -1.61 | -3.42 | -5.32 | -7.98 |
| EBITDA(a) | $-6,884 | $-3,001 | $2,664 | $972 | $-4,329 |